December 15, 2009 – Glycos Biotechnologies, Inc. (GlycosBio), an emerging biochemical company pioneering metabolic engineering and microbiology innovations that produce green chemicals, today announced the company’s inclusion in Accenture’s recent report, “Betting on Science, Disruptive Technologies in Transport Fuels”.
November 13, 2009 – Glycos Biotechnologies, Inc. (GlycosBio), a metabolic engineering innovator in biologically converting non-sugar feedstocks into next generation bioproducts, today announced Rich Cilento, Executive Chairman, will be a presenter at Alternative Energy Innovations 2009 on November 17th in Redwood City, CA.
September 3, 2009 – Glycos Biotechnologies, Inc. (GlycosBio), a metabolic engineering innovator in biologically converting non-sugar feedstocks into next generational bio-products, today announced that it has been chosen by AlwaysOn as one of the GoingGreen Top 100 Winners. Inclusion in the GoingGreen 100 signifies major developments in the creation of new business opportunities in the green technology industries. GlycosBio was specially selected by the AlwaysOn editorial team and industry experts spanning the globe for leading technologies based on a set of five criteria: innovation, market potential, commercialization, stakeholder value, and media buzz.
April 23, 2009 – Glycos Biotechnologies, Inc. (GlycosBio), a pioneer in metabolic engineering, and Eureka Genomics, a leader in analysis of next generation genomic sequencing data, announced today the sequencing of the genome of a proprietary bacterium that will support the growth of the emerging biorefinery industry. The new bacterial strain plays an important role in GlycosBio’s efforts to commercialize microbial strains to produce a variety of high-margin biochemicals from a diverse set of feedstocks and co-product streams that are traditionally considered waste or low value.
April 17, 2009 – Glycos Biotechnologies Inc., a Houston start-up company that aims to produce chemicals from low-cost, low-value carbon sources, has raised $5 million in venture capital funding.